M&A Deal Summary |
|
---|---|
Date | 2019-03-13 |
Target | Newstrike Brands |
Sector | Medical Products |
Buyer(s) | HEXO |
Deal Type | Add-on Acquisition |
Deal Value | 263M CAD |
Advisor(s) | RBC Capital Markets (Financial) Stikeman Elliott Osler (Legal) |
SEARCH BY
Try For Free 7-Day Free Trial
Category | Company |
---|---|
Founded | 2013 |
Sector | Medical Products |
Revenue | 191M USD (2022) |
HEXO is an award-winning consumer packaged goods cannabis company that creates and distributes prize-winning products to serve the global cannabis market. Through its hub and spoke business strategy, HEXO Corp is partnering with Fortune 500 companies, bringing its brand value, cannabinoid isolation technology, licensed infrastructure and regulatory expertise to established companies, leveraging their distribution networks and capacity. As one of the largest licensed cannabis companies in Canada, HEXO Corp operates with 1.8 million sq. ft of facilities in Ontario and Quebec and a foothold in Greece to establish a Eurozone processing, production and distribution centre. HEXO was founded in 2013 and is based in Gatineau, Canada.
DEAL STATS | # |
---|---|
Overall | 1 of 4 |
Sector (Medical Products) | 1 of 1 |
Type (Add-on Acquisition) | 1 of 4 |
State (Ontario) | 1 of 3 |
Country (Canada) | 1 of 4 |
Year (2019) | 1 of 1 |
Size (of disclosed) | 2 of 3 |
DATE | TARGET | DEAL TYPE | VALUE |
---|---|---|---|
2021-02-16 |
Zenabis Global
Vancouver, British Columbia, Canada Zenabis Global is a North American supplier of propagated agricultural plants growing and distributing vegetable, flower, berry and other plant seedlings. From its 34 acre production facility in Langley, BC, Zenabis supplies growers in Canada, the United States and Mexico. Zenabis Global is based in Vancouver, British Columbia. |
Buy | $235M |